MENTRIK Biotech LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.mentrik.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies
Phase 1
- Conditions
- Previously Treated CD20+ B-cell Malignancies
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2014-03-03
- Lead Sponsor
- Mentrik Biotech, LLC
- Target Recruit Count
- 9
- Registration Number
- NCT01858181
- Locations
- 🇺🇸
Universtity of Texas Southwestern Medical Center, Dallas, Texas, United States
News
No news found